Los Angeles Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$274K Sell
11,475
-41,645
-78% -$995K ﹤0.01% 1081
2025
Q1
$1.32M Sell
53,120
-22,967
-30% -$571K 0.01% 491
2024
Q4
$1.43M Sell
76,087
-69,843
-48% -$1.32M 0.01% 520
2024
Q3
$2.2M Buy
145,930
+131,934
+943% +$1.99M 0.01% 437
2024
Q2
$400K Sell
13,996
-11,192
-44% -$320K ﹤0.01% 921
2024
Q1
$736K Buy
+25,188
New +$736K ﹤0.01% 777
2023
Q4
Sell
-32,270
Closed -$990K 1212
2023
Q3
$990K Buy
32,270
+139
+0.4% +$4.27K ﹤0.01% 644
2023
Q2
$1.29M Buy
+32,131
New +$1.29M 0.01% 592
2022
Q4
Sell
-8,002
Closed -$426K 1256
2022
Q3
$426K Hold
8,002
﹤0.01% 965
2022
Q2
$467K Sell
8,002
-2,279
-22% -$133K ﹤0.01% 991
2022
Q1
$785K Buy
10,281
+731
+8% +$55.8K ﹤0.01% 860
2021
Q4
$575K Sell
9,550
-47
-0.5% -$2.83K ﹤0.01% 941
2021
Q3
$537K Sell
9,597
-425
-4% -$23.8K ﹤0.01% 1015
2021
Q2
$608K Sell
10,022
-3,255
-25% -$197K ﹤0.01% 1088
2021
Q1
$931K Sell
13,277
-10,791
-45% -$757K ﹤0.01% 926
2020
Q4
$1.44M Buy
24,068
+275
+1% +$16.5K 0.01% 783
2020
Q3
$1.43M Sell
23,793
-21,054
-47% -$1.27M 0.01% 682
2020
Q2
$2.35M Buy
44,847
+483
+1% +$25.3K 0.01% 573
2020
Q1
$1.49M Buy
44,364
+39,725
+856% +$1.33M 0.01% 613
2019
Q4
$210K Sell
4,639
-6,576
-59% -$298K ﹤0.01% 1192
2019
Q3
$427K Sell
11,215
-9,345
-45% -$356K ﹤0.01% 1028
2019
Q2
$894K Sell
20,560
-4,060
-16% -$177K ﹤0.01% 879
2019
Q1
$937K Buy
24,620
+12,060
+96% +$459K 0.01% 876
2018
Q4
$540K Buy
12,560
+2,545
+25% +$109K ﹤0.01% 947
2018
Q3
$492K Buy
10,015
+270
+3% +$13.3K ﹤0.01% 1103
2018
Q2
$312K Buy
+9,745
New +$312K ﹤0.01% 1275
2015
Q3
Sell
-3,065
Closed -$217K 1209
2015
Q2
$217K Buy
+3,065
New +$217K ﹤0.01% 1135